BHCM
ORGO icon

Brevan Howard Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Brevan Howard Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.2K Buy
+20,237
New +$49.4K ﹤0.01% 2014
2026
Q1 		– Sell
-91,033
Closed -$472K – 2389
2025
Q4 		$472K Buy
+91,033
New +$441K 0.01% 1146

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Brevan Howard Capital Management's ORGO Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Organogenesis Holdings (ORGO) in Q2 2026: 20,237 shares worth $49.2K. The stake represents ﹤0.01% of the portfolio and ranks #2014 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in ORGO as recently as Q4 2025.

Brevan Howard Capital Management first reported a position in ORGO in Q4 2025 and has held it in 2 quarters since. The position peaked at $472K in Q4 2025. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Brevan Howard Capital Management held 20,237 shares of Organogenesis Holdings worth $49.2K as of Q2 2026.
  • Organogenesis Holdings was a new Brevan Howard Capital Management position in Q2 2026.
  • Organogenesis Holdings made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #2014 holding.
  • Brevan Howard Capital Management first reported a position in Organogenesis Holdings in Q4 2025 and has held it in 2 quarters since.
  • Brevan Howard Capital Management's Organogenesis Holdings position peaked at $472K in Q4 2025.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.